logo
Rapid Synergy Berhad (KLSE:RAPID) Shareholders Should Be Cautious Despite Solid Earnings

Rapid Synergy Berhad (KLSE:RAPID) Shareholders Should Be Cautious Despite Solid Earnings

Yahoo29-05-2025
Investors appear disappointed with Rapid Synergy Berhad's (KLSE:RAPID) recent earnings, despite the decent statutory profit number. We think that they may be worried about something else, so we did some analysis and found that investors have noticed some soft numbers underlying the profit.
This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.
In high finance, the key ratio used to measure how well a company converts reported profits into free cash flow (FCF) is the accrual ratio (from cashflow). The accrual ratio subtracts the FCF from the profit for a given period, and divides the result by the average operating assets of the company over that time. This ratio tells us how much of a company's profit is not backed by free cashflow.
As a result, a negative accrual ratio is a positive for the company, and a positive accrual ratio is a negative. That is not intended to imply we should worry about a positive accrual ratio, but it's worth noting where the accrual ratio is rather high. Notably, there is some academic evidence that suggests that a high accrual ratio is a bad sign for near-term profits, generally speaking.
For the year to March 2025, Rapid Synergy Berhad had an accrual ratio of 0.26. Unfortunately, that means its free cash flow fell significantly short of its reported profits. Over the last year it actually had negative free cash flow of RM48m, in contrast to the aforementioned profit of RM20.9m. Coming off the back of negative free cash flow last year, we imagine some shareholders might wonder if its cash burn of RM48m, this year, indicates high risk. Having said that, there is more to the story. We can see that unusual items have impacted its statutory profit, and therefore the accrual ratio.
See our latest analysis for Rapid Synergy Berhad
Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Rapid Synergy Berhad.
The fact that the company had unusual items boosting profit by RM32m, in the last year, probably goes some way to explain why its accrual ratio was so weak. While we like to see profit increases, we tend to be a little more cautious when unusual items have made a big contribution. We ran the numbers on most publicly listed companies worldwide, and it's very common for unusual items to be once-off in nature. And, after all, that's exactly what the accounting terminology implies. Rapid Synergy Berhad had a rather significant contribution from unusual items relative to its profit to March 2025. All else being equal, this would likely have the effect of making the statutory profit a poor guide to underlying earnings power.
Rapid Synergy Berhad had a weak accrual ratio, but its profit did receive a boost from unusual items. Considering all this we'd argue Rapid Synergy Berhad's profits probably give an overly generous impression of its sustainable level of profitability. With this in mind, we wouldn't consider investing in a stock unless we had a thorough understanding of the risks. For instance, we've identified 4 warning signs for Rapid Synergy Berhad (1 can't be ignored) you should be familiar with.
Our examination of Rapid Synergy Berhad has focussed on certain factors that can make its earnings look better than they are. And, on that basis, we are somewhat skeptical. But there are plenty of other ways to inform your opinion of a company. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Mr D.I.Y. Group (M) Berhad Second Quarter 2025 Earnings: Misses Expectations
Mr D.I.Y. Group (M) Berhad Second Quarter 2025 Earnings: Misses Expectations

Yahoo

time27 minutes ago

  • Yahoo

Mr D.I.Y. Group (M) Berhad Second Quarter 2025 Earnings: Misses Expectations

Explore Mr D.I.Y. Group (M) Berhad's Fair Values from the Community and select yours Mr D.I.Y. Group (M) Berhad (KLSE:MRDIY) Second Quarter 2025 Results Key Financial Results Revenue: RM1.21b (up 1.5% from 2Q 2024). Net income: RM158.6m (up 2.2% from 2Q 2024). Profit margin: 13% (in line with 2Q 2024). EPS: RM0.017 (up from RM0.016 in 2Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Mr D.I.Y. Group (M) Berhad Revenues and Earnings Miss Expectations Revenue missed analyst estimates by 4.9%. Earnings per share (EPS) also missed analyst estimates by 2.6%. Looking ahead, revenue is forecast to grow 8.4% p.a. on average during the next 3 years, compared to a 7.8% growth forecast for the Specialty Retail industry in Malaysia. Performance of the Malaysian Specialty Retail industry. The company's shares are down 2.5% from a week ago. Risk Analysis You should always think about risks. Case in point, we've spotted 1 warning sign for Mr D.I.Y. Group (M) Berhad you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Carlsberg Brewery Malaysia Berhad Second Quarter 2025 Earnings: EPS: RM0.27 (vs RM0.26 in 2Q 2024)
Carlsberg Brewery Malaysia Berhad Second Quarter 2025 Earnings: EPS: RM0.27 (vs RM0.26 in 2Q 2024)

Yahoo

timean hour ago

  • Yahoo

Carlsberg Brewery Malaysia Berhad Second Quarter 2025 Earnings: EPS: RM0.27 (vs RM0.26 in 2Q 2024)

Carlsberg Brewery Malaysia Berhad (KLSE:CARLSBG) Second Quarter 2025 Results Key Financial Results Revenue: RM490.2m (down 3.4% from 2Q 2024). Net income: RM81.9m (up 3.2% from 2Q 2024). Profit margin: 17% (up from 16% in 2Q 2024). The increase in margin was driven by lower expenses. EPS: RM0.27 (up from RM0.26 in 2Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Carlsberg Brewery Malaysia Berhad Earnings Insights Looking ahead, revenue is forecast to grow 5.9% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Beverage industry in Malaysia. Performance of the Malaysian Beverage industry. The company's share price is broadly unchanged from a week ago. Risk Analysis What about risks? Every company has them, and we've spotted 2 warning signs for Carlsberg Brewery Malaysia Berhad (of which 1 is a bit concerning!) you should know about. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Lysaght Galvanized Steel Berhad Second Quarter 2025 Earnings: EPS: RM0.027 (vs RM0.067 in 2Q 2024)
Lysaght Galvanized Steel Berhad Second Quarter 2025 Earnings: EPS: RM0.027 (vs RM0.067 in 2Q 2024)

Yahoo

timean hour ago

  • Yahoo

Lysaght Galvanized Steel Berhad Second Quarter 2025 Earnings: EPS: RM0.027 (vs RM0.067 in 2Q 2024)

Lysaght Galvanized Steel Berhad (KLSE:LYSAGHT) Second Quarter 2025 Results Key Financial Results Revenue: RM19.2m (down 19% from 2Q 2024). Net income: RM1.13m (down 60% from 2Q 2024). Profit margin: 5.9% (down from 12% in 2Q 2024). The decrease in margin was driven by lower revenue. EPS: RM0.027 (down from RM0.067 in 2Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Lysaght Galvanized Steel Berhad shares are down 2.7% from a week ago. Risk Analysis You should learn about the 2 warning signs we've spotted with Lysaght Galvanized Steel Berhad. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store